[Regression under the influence of OP'DDD of a malignant cortico-adrenaloma and of its metastases (author's transl)].
Report of a case of metastatic adrenal cortical carcinoma with Cushing's syndrome treated with OP'DDD, 15 g per day. This therapy was followed by the regression of the adrenal tumour and of its metastases since three years.
D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000188:drug therapy*; D002277:Carcinoma / Q000150:complications / Q000188:drug therapy*; D003480:Cushing Syndrome / Q000150:complications; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008875:Middle Aged; D008939:Mitotane / Q000627:therapeutic use*; D009362:Neoplasm Metastasis
D008939:Mitotane
Régression par OP'DDD d'un cortico-surrénalome malin et de ses métastases.